Team:Virginia

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
-
{{VirginiaBanner}}
+
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"-->
-
{|align="justify"
+
<html xmlns="http://www.w3.org/1999/xhtml">
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
+
-
!align="center"|[[Team:Virginia|Home]]
+
-
!align="center"|[[Team:Virginia/Team|Team]]
+
-
!align="center"|[https://igem.org/Team.cgi?year=2013&team_name=Virginia Official Team Profile]
+
-
!align="center"|[[Team:Virginia/Project|Project]]
+
-
!align="center"|[[Team:Virginia/Human_Practices|Human Practices]]
+
-
!align="center"|[[Team:Virginia/Parts|Parts Submitted to the Registry]]
+
-
!align="center"|[[Team:Virginia/Modeling|Modeling]]
+
-
!align="center"|[[Team:Virginia/Notebook|Notebook]]
+
-
!align="center"|[[Team:Virginia/Safety|Safety]]
+
-
!align="center"|[[Team:Virginia/Attributions|Attributions]]
+
-
|}
+
-
<html>
+
<head>
<head>
-
<style>
+
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
 +
<title>VGEM Welcomes You!</title>
 +
<link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css">
 +
<style type="text/css">
 +
@import url("Raleway/stylesheet.css");
 +
body,td,th {
 +
font-family: Raleway, sans-serif;
 +
        font-weight:200;
 +
}
 +
body {
 +
background-color: #black;
 +
color: white;
 +
text-align: left;
 +
vertical-align: baseline;
 +
        margin:0 auto;
 +
        width:95%;
 +
        overflow:scroll;
 +
font-size:12px;
 +
}
 +
</style>
 +
<style media="screen" type="text/css">
 +
 
 +
/*hide default igem banner and reformat style into blank slate*/
 +
#globalWrapper {width: 100%;}
 +
#top-section {width: 100%; height:0px; border:none;}
 +
#p-logo {display:none; visibility:hidden;}
 +
#search-controls {display:none;}
 +
#menubar a {color:#FFFFFF;}
 +
#menubar a:hover{text-decoration:none; color:#52749C;}
 +
.left-menu {background-color:#FFFFFF; margin:0px 0px 0px 0px; padding:0;}
 +
.left-menu ul {background-color:#FFFFFF; margin:0; padding:0;}
 +
.right-menu ul li a {background-color:#CCCCCC;}
 +
.printfooter {display:none;}
 +
#footer-box {border:none;}
 +
#catlinks {display:none;}
 +
.firstHeading {display:none;}
 +
#content {width: 100%; border:none;}
 +
#bodyContent {border:none;}
 +
</style>
 +
<style media="screen" type="text/css">
 +
@font-face {
 +
font-family: 'Raleway';
 +
src: url('<link href="http://fonts.googleapis.com/css?family=Open+Sans:400,300,600,700|Raleway:400,700,200,300,900,800" rel="stylesheet" type="text/css">') format('woff');
 +
}
 +
.igemlogo {
 +
position:absolute;
 +
z-index:200;
 +
padding:20px;
 +
}
 +
.slidingpics {
 +
background-color: #000;
 +
clear: both;
 +
height: 420px;
 +
margin-left: auto;
 +
margin-left: auto;
 +
padding:10px;
 +
position:relative;
 +
z-index:1;
 +
        overflow:hidden;
 +
        padding-bottom:30px;
 +
}
 +
.fourfocus {
 +
background-color: #000;
 +
color: white;
 +
padding: 15px;
 +
height: 380px;
 +
margin-left: auto;
 +
margin-right: auto;
 +
padding-left:50px;
 +
        overflow:hidden;
 +
}
 +
 
 +
.fourfocus p {
 +
color:#6A6A6A;
 +
}
 +
.fourfocus h2 {
 +
color: #FFFFFF;
 +
}
 +
.bottom {
 +
background-color: #000;
 +
color: #FFFFFF;
 +
padding: 35px 15px 15px 15px;
 +
height: 700px;
 +
clear: both;
 +
border-top-width: 1px;
 +
border-top-style: solid;
 +
border-top-color: rgba(153,153,153,0.7);
 +
}
 +
.footer {
 +
background-color: #000000;
 +
padding: 5px;
 +
text-align: center;
 +
display: block;
 +
font-size: 12px;
 +
color: #FFFFFF;
 +
}
 +
.footer h3 {
 +
font-size: 18px;
 +
text-transform: capitalize;
 +
text-align: center;
 +
border-bottom-width: thin;
 +
border-bottom: 1px solid rgba(255,255,255,0.3);
 +
color:#FFFFFF;
 +
}
 +
.footer a {
 +
text-decoration:none;
 +
color: #E94730;
 +
}
 +
.footer a:hover {
 +
color: blue;
 +
}
 +
#picbox {
 +
margin-left:auto;
 +
margin-right:auto;
 +
width:1000px;
 +
padding-top:50px;
 +
        overflow:hidden;
 +
}
 +
#boxes {
 +
width: 1000px;
 +
margin-left: auto;
 +
margin-right:auto;
 +
        overflow:hidden;
 +
}
 +
#fbox1 {
 +
float: left;
 +
width: 235px;
 +
margin-right: 20px;
 +
text-align:center;
 +
margin-left:auto;
 +
}
 +
#fbox2 {
 +
float: left;
 +
width: 235px;
 +
margin-right: 20px;
 +
text-align:center;
 +
}
 +
#fbox3 {
 +
float: left;
 +
width: 235px;
 +
text-align:center;
 +
margin-right: 20px;
 +
}
 +
#fbox4 {
 +
float: left;
 +
width: 235px;
 +
text-align:center;
 +
}
 +
.topbanner {
 +
background-color: #000000;
 +
padding: 5px;
 +
height: 250px;
 +
position:relative;
 +
z-index:100;
 +
}
 +
#logo {
 +
height: 110px;
 +
margin: 30px auto 0px auto;
 +
}
 +
#VGEM, #logo p {
 +
margin: 0;
 +
padding: 0;
 +
}
 +
#VGEM {
 +
text-align: center;
 +
text-transform: uppercase;
 +
color:#FFFFFF;
 +
}
 +
#VGEM span {
 +
color: #E94730;
 +
}
 +
#logo p#VGEM a {
 +
font-size: 60px;
 +
color: #FFF;
 +
        font-weight:400;
 +
}
 +
#logo p {
 +
text-align: center;
 +
text-transform: uppercase;
 +
font-size: 25px;
 +
font-family: 'Raleway', sans-serif;
 +
color: #595959;
 +
}
 +
#logo p a {
 +
color:#595959;
 +
}
 +
#logo a {
 +
border: none;
 +
background: none;
 +
text-decoration: none;
 +
color: #1F1F1F;
 +
}
 +
#menu11 ul {
 +
text-transform: uppercase;
 +
font-size: 18px;
 +
line-height: 1.2em;
 +
clear: both;
 +
margin-left: auto;
 +
    margin-right:auto;
 +
    height:70px;
 +
    width:900px;       
 +
}
 +
#menu11 ul li{
 +
    display:block;
 +
    text-decoration:none;
 +
    padding:0px 0px 0px 10px;
 +
    width:150px;
 +
    height:55px;
 +
    border-left:6px dotted #fff;
 +
    float:left;
 +
}
 +
#menu11 ul li span{
 +
    display:block;
 +
}
 +
#menu11 ul li span.title{
 +
    color:#fff;
 +
list-style-type: none;
 +
}
 +
#menu11 ul li:hover{
 +
    border-left:10px dotted #E94730;
 +
}
 +
#menu11 ul li:hover span.title{
 +
list-style-type: none;
 +
}
 +
#menu11 ul li span.text{
 +
color: #325281;
 +
font-size: 14px;
 +
letter-spacing: 0px;
 +
visibility: hidden;
 +
line-height: 0px;
 +
padding-top: 8px;
 +
list-style-type: square;
 +
        background-color: #000000;
 +
        padding-bottom:2px;
 +
        padding-left:2px;
 +
        border-radius:10px;
 +
}
 +
#menu11 ul li:hover span.text{
 +
    visibility:visible;
 +
}
 +
#menu11 ul li:hover span.text a{
 +
    text-decoration:none;
 +
color:#2B60DE;
 +
}
 +
#images {
 +
    width: 900px;
 +
    height: 350px;
 +
    overflow: hidden;
 +
    position: relative;
 +
    margin: 20px auto;
 +
    }
 +
    #images img {
 +
    width: 900px;
 +
    height: 350px;
 +
    position: absolute;
 +
    top: 0;
 +
    left: -400px;
 +
    z-index: 2;
 +
    opacity: 0;
 +
    transition: all linear 500ms;
 +
    -o-transition: all linear 500ms;
 +
    -moz-transition: all linear 500ms;
 +
    -webkit-transition: all linear 500ms;
 +
    }
 +
    #images img:target {
 +
    left: 0;
 +
    z-index: 9;
 +
    opacity: 1;
 +
    }
 +
    #images img:first-child {
 +
    left: 0;
 +
    opacity:.9;
 +
    z-index:8;
 +
    }
 +
    #slider {
 +
    width:200px;
 +
    margin-left:auto;
 +
    margin-right:auto;
 +
}
 +
    #slider a {
 +
    text-decoration: none;
 +
    background: #E3F1FA;
 +
    border: 1px solid #C6E4F2;
 +
    padding: 4px 6px;
 +
    color: #222;
 +
    }
 +
    #slider a:hover {
 +
    background: #C6E4F2;
 +
    }
 +
/** WRAPPER */
 +
#featured-wrapper {
 +
overflow: hidden;
 +
width:1000px;
 +
padding: 25px 50px;
 +
background: #E54732;
 +
color: #2D2D2D;
 +
margin-left:auto;
 +
margin-right:auto;
 +
}
 +
#btitle
 +
{
 +
margin-bottom: 30px;
 +
text-transform: uppercase;
 +
font-weight: 300;
 +
font-size: 22px;
 +
color: #FFF;
 +
}
 +
#featured-wrapper span
 +
{
 +
font-size: 18px !important;
 +
color: #323232;
 +
}
 +
#sponsors
 +
{
 +
float: left;
 +
width: 330px;
 +
margin-right: 24px;
 +
}
 +
#sponsors .style4
 +
{
 +
padding-top: 10px;
 +
}
 +
#dates
 +
{
 +
float: left;
 +
width: 370px;
 +
padding: 0px 20px;
 +
}
 +
#updates
 +
{
 +
float: left;
 +
width: 200px;
 +
}
 +
p, ol, ul {
 +
margin-top: 0px;
 +
}
p {
p {
-
text-align:justify;
+
line-height: 180%;
 +
}
 +
a {
 +
color: #0000FF;
 +
}
 +
a:hover {
 +
text-decoration: none;
 +
}
 +
a img {
 +
border: none;
 +
}
 +
ul.style3
 +
{
 +
margin: 0;
 +
padding: 0;
 +
overflow: hidden;
 +
list-style: none;
 +
color: #6c6c6c
 +
}
 +
ul.style3 li
 +
{
 +
padding: 16px 0px 0px 0px;
 +
margin: 0 0 1em 0;
 +
}
 +
ul.style3 p
 +
{
 +
margin: 0;
 +
}
 +
ul.style3 a
 +
{
 +
display: block;
 +
text-decoration: none;
 +
color: #2D2D2D;
 +
}
 +
ul.style3 a:hover
 +
{
 +
text-decoration: underline;
 +
}
 +
ul.style3 h3
 +
{
 +
padding: 10px 0px 5px 0px;
 +
text-transform: uppercase;
 +
font-size: 14px;
 +
font-weight: 300;
 +
color: #FFFFFF;
 +
}
 +
ul.style3 .first
 +
{
 +
padding-top: 0;
 +
background: none;
 +
}
 +
ul.style3 .date
 +
{
 +
float: left;
 +
position: relative;
 +
width: 66px;
 +
height: 64px;
 +
margin: 0.5em 1.5em 0em 0.5em;
 +
padding: 20px 0em 0em 0em;
 +
background: #262626;
 +
border-radius: 5px;
 +
box-shadow: 0px 0px 0px 5px rgba(255,255,255,0.1);
 +
line-height: normal;
 +
text-align: center;
 +
text-transform: uppercase;
 +
text-shadow: 0px 1px 0px rgba(0,0,0,.2);
 +
font-size: 12px;
 +
font-weight: 400;
 +
color: #FFF;
 +
}
 +
ul.style3 .date:after
 +
{
 +
content: '';
 +
display: block;
 +
position: absolute;
 +
left: 0;
 +
top: 0;
 +
width: 100%;
 +
height: 100%;
 +
border-radius: 6px;
 +
}
 +
ul.style3 .date b
 +
{
 +
margin: 0;
 +
padding: 0;
 +
display: block;
 +
margin-top: -5px;
 +
font-size: 24px;
 +
font-weight: 700;
 +
color: #FFFFFF;
 +
}
 +
ul.style3 .date a
 +
{
 +
color: #FFFFFF !important;
 +
}
 +
ul.style3 .date a:hover
 +
{
 +
text-decoration: none;
 +
}
 +
ul.style4
 +
{
 +
margin: 0px;
 +
padding: 0px;
 +
list-style: none;
 +
}
 +
ul.style4 li
 +
{
 +
padding: 10px 0px 20px 0px;
 +
border-top: 1px solid rgba(255,255,255,0.3);
 +
}
 +
ul.style4 a
 +
{
 +
color: #2D2D2D;
 +
text-decoration: underline;
 +
}
 +
ul.style4 .first
 +
{
 +
padding-top: 0px;
 +
border-top: none;
 +
}
 +
/* Button Style 1 */
 +
.button-style {
 +
display: inline-block;
 +
margin-top: 20px;
 +
padding: 7px 20px;
 +
background: #272727;
 +
border-radius: 5px;
 +
text-decoration: none;
 +
text-transform: uppercase;
 +
color: #FFFFFF;
 +
}
 +
.button-style-alt
 +
{
 +
background: #E94730;
 +
padding: 15px 20px;
 +
font-size: 14px;
 +
font-weight: 600;
}
}
</style>
</style>
 +
</head>
</head>
<body>
<body>
-
<h3>Preliminary Description:</h3>
+
<div class="igemlogo">
 +
<a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/igem.org/1/17/IGEM_basic_Logo_white_stylized.png" width="70"> </a>
 +
</div>
 +
<div class="topbanner">
 +
  <div id="logo">
 +
<p id="VGEM"><a href="https://2013.igem.org/VirginiaTemplate3"><span>V</span>GEM</a></p>
 +
<p><a href="http://www.virginia.edu/"> University of Virginia</a></p>
 +
</div>
 +
  <div id="menu11">
 +
    <ul>
 +
        <li>
 +
                <span class="title">Home</span>
 +
                <span class="text"><a href="https://2013.igem.org/VirginiaTemplate3">The start</a></span>
 +
        </li>
 +
        <li>
 +
        <span class="title">Project</span>
 +
                <span class="text">
 +
                <p><a href="">Overview</a></p>
 +
                <p><a href="">Background</a></p>
 +
                <p><a href="">Parts</a></p>
 +
                <p><a href="">Results</a></p>
 +
                <p><a href="">Modeling</a></p>
 +
                <p><a href="">More Applications</a></p></span>
 +
        </li>
 +
        <li>
 +
                <span class="title">Notebook</span>
 +
                <span class="text">
 +
                <p><a href="">Overview</a></p>
 +
                <p><a href="">Notebook</a></p>
 +
                <p><a href="">Protocols</a></p>
 +
                <p><a href="">Gallery</a></p></span>
 +
        </li>
 +
        <li>
 +
                <span class="title">Human Practices</span>
 +
                <span class="text">
 +
                <p><a href="">Overview</a></p>
 +
                <p><a href="">Safety</a></p>
-
<h4> <b>Minicells </b>
+
                <p><a href="">Clinical Impact</a></p>
-
</h4>
+
          <p><a href="">Outreach</a></p></span>
-
 
+
        </li>
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Uneven cellular division in bacteria can yield a normal parent cell and an achromosomal “minicell”. At 400 nm, <i>E. coli</i> minicells are much smaller than their parental cells. Their lack of chromosomal DNA renders them unable to replicate and cause infection, yet they still retain and express plasmid genes (Mugridge). Additionally, minicells have stable, non-leaky membranes and inherit the cytosolic composition of their parent cell, maintaining the same protein and ion concentrations (Frazer). Since their plasma membranes are derived from the parent cell, minicells also retain any targeting systems put in place before their production. Perhaps the best complements to minicells’ modularity, membrane-bound antibodies enable highly-specific and effective targeting of minicells to specific cells (MacDiarmid). These unique qualities make minicells a viable and safer alternative to comparable chassis such as liposomes and standard <i>E. coli</i>.
+
        <li>
-
</p>
+
                <span class="title">Team</span>
-
 
+
  <span class="text">
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Minicells hold great potential in a synthetic biology context. We aim to create a standard BioBrick that induces minicell formation in <i>E. coli</i> cells and to design additional safeguards to make our chassis as safe as possible. Research has shown that the overproduction of the tubulin-homolog FtsZ leads to minicell formation (Ward). Accordingly, we designed a simple BioBrick to contain the <i>ftsz</i> gene under the control of an IPTG-inducible promoter. This allows us to adjust FtsZ production to achieve optimal minicell production. We are simultaneously developing a quantitative model that relates the amount of IPTG added to the final concentration of minicells that are produced and purified.
+
                <p><a href="https://2013.igem.org/VirginiaTemplateTeamOverview">Overview</a></p>
-
</p>
+
                <p><a href="https://2013.igem.org/VirginiaTemplateTeamBios">Bios</a></p>
-
 
+
                <p><a href="https://igem.org/Team.cgi?year=2013&team_name=Virginia">Profile</a></p>
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Despite minicells’ inability to replicate, their safety for medicinal use remains an utmost concern. To address this, we seek to reduce— or even eliminate— the threat of an inflammatory response induced through the presence of lipopolysaccharide (LPS) and via complement deposition. The Ail protein from Yersinia pestis is especially promising in that regard, as it confers resistance to the human innate immune response (Kolodziejek). We have also explored the possibility of encapsulating our chassis with polysialic acid, mimicking the mammalian structures typically associated with the neural cell adhesion molecule (NCAM). Sialylation would further reduce complement deposition, as well as antibody opsonization. In other words, both Ail and polysialic acid can be produced in concert with our original FtsZ BioBrick to create safer minicells in a desired strain of <i>E. coli</i>. As an additional safety precaution, we also decided to use the <i>lpxM</i> mutant strain, which has a reduction in the acyl-group modifications of the conserved Lipid A portion of its LPS. Studies have shown that this variant can reduce E-selectin stimulation and TNF-α production by up to 10,000-fold (Anisimov). Combined, these three safeguards could hence significantly slash the immunogenicity and risks associated with a minicell chassis.
+
                <p><a href="">Sponsors</a></p>
-
</p>
+
      <p><a href="">Collaboration</a></p></span></li>
-
 
+
    </ul></div></div>
-
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In conclusion, minicells lack the ability to replicate and therefore carry virtually no risk of infection, which is especially important for the young, the elderly, or the immunocompromised. The Ail, polysialic acid and <i>IpxM</i> mutant modifications we will implement will further enhance their innate safety, lowering associated health risks. By combining multiple safety elements with an inherent ease of production and modularity, we hope to showcase minicells' potential as a chassis for widespread therapeutic use and consumption.
+
<div class="slidingpics">
-
</p>
+
    <div id="images">
-
 
+
    <img id="image1" src="http://25.media.tumblr.com/765b5d018f23f5f6cd8fdb0e9e25cc29/tumblr_mq3ju4HxSl1sxgpaeo5_r1_1280.jpg" />
-
<p></p>
+
    <img id="image2" src="http://24.media.tumblr.com/c39c53bb19f95595c476048e991e5e5b/tumblr_mq3ju4HxSl1sxgpaeo2_1280.jpg" />
-
<h6><b>Sources</b></h6>
+
    <img id="image3" src="http://25.media.tumblr.com/1bc07c1301c04a218de791a38c360b05/tumblr_mq3ju4HxSl1sxgpaeo3_1280.jpg" />
-
<h6>Anisimov, A., Shalkhutdinova, R., Pan, L., Feodorova, V., Savostina, E., Bystrova, O., Lindner, B., & Mokrievich, A. (2007). Effect of deletion of the lpxm gene on virulence and vaccine potential of yersinia pestis in mice. Journal of Medical Microbiology, 56(4), 443-53. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17374882?dopt=AbstractPlus </h6>
+
    <img id="image4" src="http://25.media.tumblr.com/0563475beb34af40a8b357dcad87fb5e/tumblr_mq3ju4HxSl1sxgpaeo1_1280.jpg" />
-
 
+
    <img id="image5" src="http://25.media.tumblr.com/625692582f4983dc4db9bb81b2298d35/tumblr_mq3ju4HxSl1sxgpaeo4_1280.jpg" />
-
<h6>Frazer, A. & Curtiss, 3rd R. (1975). Production, properties and utility of bacterial minicells. Current Topics in Microbiology and Immunology. 69, 1–84.</h6>
+
    </div>
-
 
+
    <div id="slider">
-
<h6>Kolodziejek, A., Schnider, D., Rohde, H., Wojtowicz, A., Bohach, G., Minnich, S., & Hovde, C. (2010). Outer membrane protein x (ail) contributes to yersinia pestis virulence in pneumonic plague and its activity is dependent on the lipopolysaccharide core length. Infectious Immunology, 78(12), 5233-43. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20837715</h6>
+
    <a href="#image1">1</a>
-
 
+
    <a href="#image2">2</a>
-
<h6>MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., et al. (2007). Bacterially derived 400 nm particles for encapsulation and cancer cells targeting of chemotherapeutics. Cancer Cell, 11(5), 431-45. </h6>
+
    <a href="#image3">3</a>
-
 
+
    <a href="#image4">4</a>
-
<h6>Ward, J.E., Lutkenhaus, J. (1985). Overproduction of FtsZ induces minicell formation in Escherichia-coli. Cell, 42(3), 941-9.  
+
    <a href="#image5">5</a>
-
</h6>
+
    </div>
 +
<!--<div id="picbox"><img src="http://24.media.tumblr.com/97a47d3aa55da6f5985d81b4fd7dfb27/tumblr_mp2gt0CjGe1sxgpaeo1_1280.jpg" width="1000" height="350"/></div>-->
 +
</div>
 +
<div class="fourfocus">
 +
  <div id="boxes"><div id="fbox1"><a href=""><img src="http://24.media.tumblr.com/579c7d1022612a7d4824b443c7c85c0b/tumblr_mpqf8cpFsA1sxgpaeo2_250.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Project</h2>
 +
<p>Learn more about the exciting developments of minicells as a safe and effective chassis.</p>
 +
  </div>
 +
  <div id="fbox2"><a href=""><img src="http://24.media.tumblr.com/e5f36d51fa3819e9cf24212f57c91cbf/tumblr_mpqf8cpFsA1sxgpaeo3_1280.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Notebook</h2>
 +
<p>See how we spent our summer of science.</p>
 +
  </div>
 +
<div id="fbox3"><a href=""><img src="http://24.media.tumblr.com/608c60f8004dd567b522f6fd475b1155/tumblr_mpqf8cpFsA1sxgpaeo4_1280.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Human Practices</h2>
 +
<p>Discover the local and global impact our iGEM team has made.</p>
 +
</div>
 +
<div id="fbox4"><a href=""><img src="http://24.media.tumblr.com/4ffef8a1fd2b071b6ec6ffe26320ddb4/tumblr_mpqfdg3MC11sxgpaeo1_1280.jpg" width="235" height="235" alt="" /></a>
 +
<h2>Team</h2>
 +
<p>Meet the brains and brawn behind the project.</p>
 +
</div></div>
 +
</div>
 +
<div class="bottom">
 +
<div id="featured-wrapper">
 +
<div id="sponsors">
 +
<div id="btitle"><p>Sponsors<br/>
 +
<span>Funding the Science</span></p></div>
 +
<p>Without our sponsors, this year's iGEM team would not be in existence. Thank you.</p>
 +
<ul class="style4">
 +
<li class="first"><a href="http://www.virginia.edu/vpr/biography.html">Tom Skalak, Vice President of Research at UVA</a></li>
 +
<li><a href="http://medicine.virginia.edu/">UVA Medical School</a></li>
 +
<li><a href="http://seas.virginia.edu/">UVA School of Engineering and Applied Science</a></li>
 +
                <li><a href="http://artsandsciences.virginia.edu/home/index.html">UVA College of Arts and Sciences</a></li>
 +
                <li><a href="#">Alumni Lacy Fund</a></li>
 +
</ul>
 +
<a href="#" class="button-style">Official Sponsors Page</a> </div>
 +
<div id="dates">
 +
<p id="btitle">Competition Events<br/>
 +
<span>Next Stop: Canada!</span></p>
 +
<ul class="style3">
 +
<li class="first">
 +
<p class="date">September<b>18</b></p>
 +
<h3>Biobrick Part Due</h3>
 +
<p><a href="http://parts.igem.org/Main_Page">All DNA due to the iGEM registry.</a></p>
 +
</li>
 +
<li>
 +
<p class="date">October<b>4-6</b></p>
 +
<h3>North America Regional Jamboree</h3>
 +
<p><a href="http://www.utoronto.com/">University of Toronto, Ontario, CA</a></p>
 +
</li>
 +
<li>
 +
<p class="date">November<b>1-4</b></p>
 +
<h3>World Championship Jamboree</h3>
 +
<p><a href="http://www.mit.edu/">MIT, Cambridge, USA</a></p>
 +
</li>
 +
<li>
 +
</ul>
 +
</div>
 +
<div id="updates">
 +
<p id="btitle">Recent Updates<br />
 +
<span>Team Progress</span></p>
 +
<ul class="style4">
 +
<li class="first">Photo Shoot Complete</li>
 +
<li>Toronto Hotel Booked</li>
 +
<li>Parts Sequenced Correctly</li>
 +
<li>Minicells formed</li>
 +
<li>Business Cards Ordered</li>
 +
<li>Intrexon Tour Scheduled</li>
 +
</ul>
 +
</div>
 +
</div>
 +
<div class="footer">
 +
<h3>&nbsp;</h3>
 +
<h3>Contact</h3>
 +
<p>Questions? Comments? Email us at <a href="virginia.igem@gmail.com">virginia.igem@gmail.com</a></p>
 +
</div>
 +
   
 +
<p>&nbsp;</p>
</body>
</body>
</html>
</html>
-
|-
 
-
|
 
-
|}
 
-
 
-
<!--- The Mission, Experiments --->
 

Revision as of 19:58, 21 September 2013

VGEM Welcomes You!

1 2 3 4 5

Project

Learn more about the exciting developments of minicells as a safe and effective chassis.

Notebook

See how we spent our summer of science.

Human Practices

Discover the local and global impact our iGEM team has made.

Team

Meet the brains and brawn behind the project.

 

Contact

Questions? Comments? Email us at virginia.igem@gmail.com

 

Retrieved from "http://2013.igem.org/Team:Virginia"